Citations

Citations to this article as recorded by  

• Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
  Bin Wan, Jing Hu, Yue Luo, Yutong Han, Yaowen Zhang, Qinchuan Huang, Yulin Leng, Chunguang Xie
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Identification and validation of endoplasmic reticulum stress-related diagnostic biomarkers for type 1 diabetic cardiomyopathy based on bioinformatics and machine learning
  Qiao Tang, Yanwei Ji, Zhongyuan Xia, Yuxi Zhang, Chong Dong, Qian Sun, Shaoqing Lei
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Traditional Chinese medicine in the prevention of diabetes mellitus and cardiovascular complications: mechanisms and therapeutic approaches
  Caixia Chen, Hui Gao, Ying Wei, Yaxi Wang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
  Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan,
  Current Problems in Cardiology.2024; 49(1): 102052.     CrossRef
• Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
  Yun Huang, Hua Zhou, Chongbo Fang, Lili Ma, Yuyu Zhang, Weibo Rong, Xiaoli Liu, Honghua Ye
  Journal of Cardiovascular Pharmacology.2024; 83(1): 86.     CrossRef
• Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy
  Jie Li, Yingying Xie, Shuwen Zheng, Haoming He, Zhe Wang, Xuexi Li, Siqi Jiao, Dong Liu, Furong Yang, Hailing Zhao, Ping Li, Yihong Sun
  Biomedicine & Pharmacotherapy.2024; 175: 116790.     CrossRef
• Exploring therapeutic targets and molecular mechanisms for treating diabetes mellitus-associated heart failure with Qishen Yiqi dropping pills: A network pharmacology and bioinformatics approach
  Yirong Ma, Junyu Lai, Zhengtao Chen, Qiang Wan, Xianlin Shi, Hao Zhou, Jiaming Li, Zurong Yang, Jianguang Wu
  Medicine.2024; 103(31): e39104.     CrossRef
• Evaluation of newly-developed glycated hemoglobin clinical analytic reagents and chromatography column on Tosoh HLC-723 G8 Analyzer
  Bo Yuan, Wei Yang, Na Zhang, Hongyan Shi, Shuangpeng Dong
  Practical Laboratory Medicine.2023; 37: e00338.     CrossRef
• Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction
  Dane Rucker, Jacob Joseph
  Current Heart Failure Reports.2022; 19(6): 445.     CrossRef

Citations

Citations to this article as recorded by  

• Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression
  Seung-Hwan Lee, Kyu Na Lee, Jong-Chan Youn, Hun Sung Kim, Kyungdo Han, Mee Kyoung Kim
  Diabetes & Metabolism Journal.2025; 49(1): 105.     CrossRef
• High mRNA Expression of 24 Dehydrocholesterol Reductase (DHCR24) in the Treatment of Doxorubicin-Induced Heart Failure in Rats
  Rui Zhang, Siyuan Peng, Xuejuan Zhang, Zhengwei Huang, Xin Pan
  International Journal of Molecular Sciences.2025; 26(1): 312.     CrossRef
• Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial
  Heba Serag, Lamia El Wakeel, Viola William, Mona Abdelsalam, Ahmed Abdelsalam, Rana Sayed
  Scientific Reports.2025;[Epub]     CrossRef
• Diabète, inflammation et maladies cardiovasculaires : avancées thérapeutiques et rôle clé de la colchicine
  Rémi Arnold, Nidal Jammoul, Quentin Delbaere, François Roubille
  Médecine des Maladies Métaboliques.2025; 19(2): 153.     CrossRef
• Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure—A prospective cohort study
  Vladimir Cejka, Hermann Riepl, Nora Schwegel, Ewald Kolesnik, David Zach, Viktoria Santner, Viktoria Höller, Natascha Schweighofer, Barbara Obermayer‐Pietsch, Thomas Pieber, Caroline Morbach, Stefan Frantz, Andreas Zirlik, Dirk von Lewinski, Stefan Störk,
  ESC Heart Failure.2025;[Epub]     CrossRef
• Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus
  Mohammadjavad Sotoudeheian, Seyed-Mohamad-Sadegh Mirahmadi, Pedram Salehi Darjani, Mohammad Moradi, Mohammad Pirhayati, Mohammad Sedigh Dakkali, Mehdi Taghizadeh, Reza Azarbad, Hamidreza Pazoki Toroudi
  Diabetology International.2025; 16(2): 237.     CrossRef
• Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review
  Héctor Fuentes-Barría, Raúl Aguilera-Eguía, Cherie Flores-Fernández, Lissé Angarita-Davila, Diana Rojas-Gómez, Miguel Alarcón-Rivera, Olga López-Soto, Juan Maureira-Sánchez
  International Journal of Molecular Sciences.2025; 26(5): 2153.     CrossRef
• The Role of Resistin in Macrovascular and Microvascular Complications of Type 2 Diabetes
  Africa Samantha Reynoso-Roa, Susan Andrea Gutiérrez-Rubio, Ezequiel Magallón-Gastélum, Trinidad García-Iglesias, Daniel Osmar Suárez-Rico, Teresa Arcelia García-Cobián
  Life.2025; 15(4): 585.     CrossRef
• Type 2 diabetes increases the risk of mortality and cardiovascular events in ischemic HFmrEF patients: a retrospective cohort study
  Zhican Liu, Hailong Hu, Jianping Zeng, Mingyan Jiang
  Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
• Research Progress on Metabolic Disorders Associated with Diabetic Cardiomyopathy
  佳君 丁
  Advances in Clinical Medicine.2025; 15(04): 1504.     CrossRef
• The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
  Xiangling Duan, Xiaomeng Zhang, Bao Sun
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis
  Yundong Peng, JiePing Wang, Xinyao Liu, Yanqing Zhou, Shaohui Jia, Jinrong Xu, Cheng Zheng
  Annals of Vascular Surgery.2024; 98: 365.     CrossRef
• Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
  Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan,
  Current Problems in Cardiology.2024; 49(1): 102052.     CrossRef
• Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes
  Rachel E. Aaron, Tiffany Tian, G. Alexander Fleming, David B. Sacks, James L. Januzzi, MD FACC, Rodica Pop-Busui, Ibrahim A. Hashim, Alan H. B. Wu, Ambarish Pandey, David C. Klonoff
  Journal of Diabetes Science and Technology.2024; 18(3): 733.     CrossRef
• Research Progress on the Relationship between HbA_1c and Diabetes Complicated with Chronic Heart Failure
  ·依沙 迪达尔
  Advances in Clinical Medicine.2024; 14(01): 1117.     CrossRef
• Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
  Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin, Che-Huei Lin, Ming-Hung Lin
  Journal of Cardiovascular Pharmacology and Therapeutics.2024;[Epub]     CrossRef
• The Role of Epicardial Adipose Tissue in Acute Coronary Syndromes, Post-Infarct Remodeling and Cardiac Regeneration
  Kamil Krauz, Marcel Kempiński, Paweł Jańczak, Karol Momot, Maciej Zarębiński, Izabela Poprawa, Małgorzata Wojciechowska
  International Journal of Molecular Sciences.2024; 25(7): 3583.     CrossRef
• Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy
  Yue Zeng, Yilang Li, Wenyue Jiang, Ning Hou
  Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
• Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography
  Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
  Diabetes & Metabolism.2024; 50(3): 101534.     CrossRef
• SGLT2 Inhibitors in the Cardiovascular Disease
  Jin Joo Park
  The Journal of Korean Diabetes.2024; 25(1): 26.     CrossRef
• Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer
  Antonino Colloca, Isabella Donisi, Camilla Anastasio, Maria Luisa Balestrieri, Nunzia D’Onofrio
  Cells.2024; 13(8): 663.     CrossRef
• Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
  Lu Zhao, Haoran Hu, Lin Zhang, Zheting Liu, Yunchao Huang, Qian Liu, Liang Jin, Meifei Zhu, Ling Zhang
  MedComm.2024;[Epub]     CrossRef
• Methods to predict heart failure in diabetes patients
  Alexander E. Berezin, Tetiana A Berezina, Uta C. Hoppe, Michael Lichtenauer, Alexander A. Berezin
  Expert Review of Endocrinology & Metabolism.2024; 19(3): 241.     CrossRef
• Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure
  Tianqing Zhang, Li Luo, Qi He, Sijie Xiao, Yuwei Li, Junpeng Chen, Tao Qin, Zhenni Xiao, Qingliang Ge
  European Journal of Medical Research.2024;[Epub]     CrossRef
• The latest emerging drugs for the treatment of diabetic cardiomyopathy
  Minghao Li, Lin Liu, Chunyu Zhang, Li Deng, Yi Zhong, Bin Liao, Xiuying Li, Ying Wan, Jian Feng
  Expert Opinion on Pharmacotherapy.2024; 25(6): 641.     CrossRef
• Prevalencia de insuficiencia cardiaca diagnosticada en pacientes diabéticos en el ámbito de la atención primaria. ¿Debemos mejorar el cribado?
  Manuel Sánchez Molla, Juan Manuel Zazo Menargues, Inmaculada Candela Garcia
  Atención Primaria.2024; 56(7): 102952.     CrossRef
• Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy
  Jie Li, Yingying Xie, Shuwen Zheng, Haoming He, Zhe Wang, Xuexi Li, Siqi Jiao, Dong Liu, Furong Yang, Hailing Zhao, Ping Li, Yihong Sun
  Biomedicine & Pharmacotherapy.2024; 175: 116790.     CrossRef
• Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy
  Lamiaa Mohamed Mahmoud, Aya Aly Ashraf Abdel Mageed, Jackline Moawad Saadallah, Mira Farouk Youssef, Liala Ahmed Rashed, Hania Ibrahim Ammar
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(10): 8023.     CrossRef
• Heart failure phenotypes and clinical and laboratory features of patients with type 2 diabetes in inpatient endocrinology and cardiology practice
  T. Yu. Demidova, M. Ya. Izmaylova
  Meditsinskiy sovet = Medical Council.2024; (6): 81.     CrossRef
• Potential molecular and cellular mechanisms of the effects of cuproptosis-related genes in the cardiomyocytes of patients with diabetic heart failure: a bioinformatics analysis
  Jinhao Chen, Xu Yang, Weiwen Li, Ying Lin, Run Lin, Xianzhen Cai, Baoxin Yan, Bin Xie, Jilin Li
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions
  Shashipriya Agress, Jannat S. Sheikh, Aida A. Perez Ramos, Durlav Kashyap, Soha Razmjouei, Joy Kumar, Mankaranvir Singh, Muhammad Ali Lak, Ali Osman, Muhammad Zia ul Haq
  Current Cardiology Reviews.2024;[Epub]     CrossRef
• Prescripción de antihipertensivos en personas con diabetes tipo 2 en Andalucía y recomendaciones SEH-LELHA 2022: evaluación del coste y uso
  D. Martín-Enguix, J.C. Aguirre Rodríguez, M. Guisasola Cárdenas, M.N. Generoso Torres, A. Hidalgo Rodríguez, M. Sánchez Cambronero, A. González Bravo
  Hipertensión y Riesgo Vascular.2024; 41(4): 226.     CrossRef
• Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study
  Matteo Landolfo, Francesco Spannella, Federico Giulietti, Beatrice Ortensi, Lucia Stella, Maria A. Carlucci, Roberta Galeazzi, Federica Turchi, Maria P. Luconi, Roberto Zampa, Sofia Cecchi, Elena Tortato, Massimiliano Petrelli, Riccardo Sarzani
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis
  Xiao-fei Geng, Wen-yu Shang, Zhong-wen Qi, Chi Zhang, Wen-xiu Li, Zhi-peng Yan, Xin-biao Fan, Jun-ping Zhang
  Journal of Diabetes and its Complications.2024; 38(10): 108848.     CrossRef
• The effects of resistance training on cardiovascular factors and anti-inflammation in diabetic rats
  Jin Yoo, Jinsu Hwang, Jiyun Choi, Mahesh Ramalingam, Haewon Jeong, Sujeong Jang, Han-Seong Jeong, Daeyeol Kim
  Heliyon.2024; 10(17): e37081.     CrossRef
• The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta‐analysis
  Mahtab Tabesh, Julian W. Sacre, Kanika Mehta, Lei Chen, Seyeddeh Forough Sajjadi, Dianna J. Magliano, Jonathan E. Shaw
  Diabetes, Obesity and Metabolism.2024; 26(12): 5690.     CrossRef
• Metabolomic Profiling Reveals That Exercise Lowers Biomarkers of Cardiac Dysfunction in Rats with Type 2 Diabetes
  Tutu Wang, Miaomiao Ning, Yurou Mo, Xinyu Tian, Yu Fu, Ismail Laher, Shunchang Li
  Antioxidants.2024; 13(10): 1167.     CrossRef
• Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs
  Jiali Yin, Xinjun Xu, Ying Guo, Caiyu Sun, Yujuan Yang, Huifang Liu, Pengyi Yu, Tong Wu, Xicheng Song
  Cell Death Discovery.2024;[Epub]     CrossRef
• Management of a Dual Low Sodium and Diabetic Diet by Patient-Caregiver Dyads: A Qualitative Descriptive Study
  Leigh Anne DeNotto, Misook L. Chung, Kaitlin Voigts Key, Gia Mudd-Martin
  The Science of Diabetes Self-Management and Care.2024; 50(6): 520.     CrossRef
• The triglyceride-glucose index, ventricular arrhythmias and major cardiovascular events in patients at high risk of sudden cardiac death
  Yuan Gao, Zhuxin Zhang, Mengxing Cai, Zhongli Chen, Sijin Wu, Jiandu Yang, Xiaogang Guo, Ruohan Chen, Yan Dai, Shu Zhang, Xiaoyao Li, Qi Sun, Keping Chen
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• Sodium-glucose cotransporter 2 inhibitors in cardiocerebrovascular disease
  Jin Joo Park
  Cardiovascular Prevention and Pharmacotherapy.2024; 6(4): 103.     CrossRef
• Insulin Resistance–Nutritional Index: A Simple Index and Potential Predictor of Mortality Risk in Patients with Chronic Heart Failure and Type 2 Diabetes
  You Zhou, Yingli Xie, Jingjing Dong, Kunlun He, Hebin Che
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 4177.     CrossRef
• The prognostic value of cartilage intermediate layer protein 1 (CILP1) in patients with diabetic cardiomyopathy
  Li Xiang, Xiang Liu, Xuehua Jiao, Zhenguo Qiao
  BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
• Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review
  Francisco Epelde
  Medicina.2024; 60(12): 1986.     CrossRef
• Long-term outcomes of unselected patients undergoing coronary angiography according to the presence or absence of type II diabetes mellitus
  Philipp Steinke, Tobias Schupp, Lasse Kuhn, Mohammad Abumayyaleh, Mohamed Ayoub, Kambis Mashayekhi, Thomas Bertsch, Niklas Ayasse, Mahboubeh Jannesari, Fabian Siegel, Daniel Dürschmied, Michael Behnes, Ibrahim Akin
  Cardiovascular Revascularization Medicine.2024;[Epub]     CrossRef
• Peripheral arterial atherosclerosis and heart failure: state of the art review
  V. V. Genkel, O. V. Latysheva, S. V. Ershov, E. V. Lebedev, A. S. Kuznetsova, A. O. Salashenko, I. I. Shaposhnik
  South Russian Journal of Therapeutic Practice.2024; 5(4): 15.     CrossRef
• Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
  Nawfal Hasan Siam, Nayla Nuren Snigdha, Noushin Tabasumma, Irin Parvin
  Reviews in Cardiovascular Medicine.2024;[Epub]     CrossRef
• Effects of multidisciplinary collaborative treatment in patients with chronic heart failure
  Wei Song
  American Journal of Translational Research.2024; 16(12): 7803.     CrossRef
• Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
  Andrew Xanthopoulos, Nikolaos Katsiadas, Spyridon Skoularigkis, Dimitrios E. Magouliotis, Niki Skopeliti, Sotirios Patsilinakos, Alexandros Briasoulis, Filippos Triposkiadis, John Skoularigis
  Life.2023; 13(8): 1778.     CrossRef
• Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism
  Bo Liang, Rui Li, Peng Zhang, Ning Gu
  Journal of Cardiovascular Translational Research.2023; 16(2): 327.     CrossRef
• Causes and Determinants of Heart Failure Readmissions Post Transcutaneous Aortic Valve Replacement: A Systematic Review and Meta-Analysis
  Farah Yasmin, Muhammad Aamir, Abdul Moeed, Kinza Iqbal, Aymen Iqbal, Muhammad Sohaib Asghar, Waqas Ullah, Indranee Rajapreyar, Yevgeniy Brailovsky
  Current Problems in Cardiology.2023; 48(1): 101428.     CrossRef
• Discussion of a study on the role of EMS in prognosis of elderly patients with AHF
  Qingzhuo Yang, Hui Wu, Di Liu, Yunzhao Li, Gang Zhou, Dong Zhang, Yanfang Liu, Yi Li
  International Journal of Cardiology.2023; 377: 91.     CrossRef
• The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease
  Yi Zhang, Chao Liu, Yijing Xu, Yanlei Wang, Fang Dai, Honglin Hu, Tian Jiang, Yunxia Lu, Qiu Zhang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
  Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
  International Journal of Heart Failure.2023; 5(1): 1.     CrossRef
• Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
  Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
  Diabetes & Metabolism Journal.2023; 47(1): 10.     CrossRef
• Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients
  Tetiana Berezina, Mykola Kopytsya, Olga Petyunina, Alexander Berezin, Zeljko Obradovic, Lukas Schmidbauer, Michael Lichtenauer, Alexander Berezin
  Cardiogenetics.2023; 13(1): 15.     CrossRef
• Novel model predicts diastolic cardiac dysfunction in type 2 diabetes
  Mingyu Hao, Xiaohong Huang, Xueting Liu, Xiaokang Fang, Haiyan Li, Lingbo Lv, Liming Zhou, Tiecheng Guo, Dewen Yan
  Annals of Medicine.2023; 55(1): 766.     CrossRef
• Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide‐induced ERK/Egr‐1 pathway
  Qing Wu, Ming Zhao, Dongling Li, Xi He, Weijin Zang
  The FASEB Journal.2023;[Epub]     CrossRef
• Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
  Yangting Zhao, Binjing Pan, Xiaoyu Lv, Chongyang Chen, Kai Li, Yawen Wang, Jingfang Liu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Cardiorenal syndrome and diabetes: an evil pairing
  Ana Belén Méndez Fernández, Ander Vergara Arana, Aleix Olivella San Emeterio, Maria Antonieta Azancot Rivero, Toni Soriano Colome, Maria Jose Soler Romeo
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Therapeutic Potential of Hibiscus sabdariffa Linn. in Attenuating Cardiovascular Risk Factors
  Syaifuzah Sapian, Asma Ali Ibrahim Mze, Fatin Farhana Jubaidi, Nor Anizah Mohd Nor, Izatus Shima Taib, Zariyantey Abd Hamid, Satirah Zainalabidin, Nur Najmi Mohamad Anuar, Haliza Katas, Jalifah Latip, Juriyati Jalil, Nur Faizah Abu Bakar, Siti Balkis Budi
  Pharmaceuticals.2023; 16(6): 807.     CrossRef
• Exploring the prospect of intrinsic wave propagation in evaluating myocardial stiffness among patients with type 2 diabetes
  Qiao Cheng, Xiao Huang, Xinying Fan, Jie Sun, Jun Zhang, Qiaoying Tang, Youbin Deng, Xiaojun Bi
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• The multidimensional prognostic index (MPI) predicts long-term mortality in old type 2 diabetes mellitus patients: a 13-year follow-up study
  F. Salis, E. Cossu, A. Mandas
  Journal of Endocrinological Investigation.2023; 47(1): 191.     CrossRef
• PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy
  Tongtong Hu, Qingqing Wu, Qi Yao, Jiabin Yu, Kebing Jiang, Ying Wan, Qizhu Tang
  Metabolism.2023; 146: 155658.     CrossRef
• Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
  Michael Gotzmann, Pauline Henk, Ulrik Stervbo, Arturo Blázquez-Navarro, Andreas Mügge, Nina Babel, Timm H. Westhoff
  Journal of Clinical Medicine.2023; 12(13): 4458.     CrossRef
• Features of the course and complications of acute myocardial infarction in type 2 diabetes mellitus
  M. N. Zatsepina, F. O. Ushanova, T. L. Bogacheva
  FOCUS. Endocrinology.2023; 4(2): 42.     CrossRef
• Admission Triglyceride-Glucose Index Is Predictor of Long-Term Mortality and Appropriate Implantable Cardiac Defibrillator Therapy in Patients with Heart Failure
  Kazım S Özcan, Mert İ Hayıroğlu, Tufan Çınar
  Biomarkers in Medicine.2023; 17(10): 487.     CrossRef
• Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders
  Antonietta Fazio, Camilla Evangelisti, Alessandra Cappellini, Sara Mongiorgi, Foteini-Dionysia Koufi, Irene Neri, Maria Vittoria Marvi, Michele Russo, Alessandra Ghigo, Lucia Manzoli, Roberta Fiume, Stefano Ratti
  International Journal of Molecular Sciences.2023; 24(17): 13096.     CrossRef
• Research progress of dihydromyricetin in the treatment of diabetes mellitus
  Ziyuan Wang, Zhuoran Cao, Zhiying Yue, Zhengfeng Yang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work
  Guang-An Li, Jun Huang, Xiao Sheng, Li Fan
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Managing heart failure in diabetics with dual acting sotagliflozin—A review
  Kushal Seni, Pooja A Chawla
  Health Sciences Review.2023; 9: 100130.     CrossRef
• Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study
  Shuping Yang, Xiangxiang Shi, Wanlu Liu, Zhaokai Wang, Ruoshui Li, Xianzhi Xu, Chaofan Wang, Lei Li, Ruili Wang, Tongda Xu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Influence of Sociodemographic Variables and Healthy Habits on the Values of Insulin Resistance Indicators in 386,924 Spanish Workers
  Miguel Mestre Font, Carla Busquets-Cortés, José Ignacio Ramírez-Manent, Pilar Tomás-Gil, Hernán Paublini, Ángel Arturo López-González
  Nutrients.2023; 15(24): 5122.     CrossRef
• PDE-5-Inhibited BMSCs Alleviate High Glucose-Induced Myocardial Fibrosis and Cardiomyocyte Apoptosis by Activating the cGMP/PKG Pathway
  Qinghua Huang, Jiangbo Ma, Hui Wu, Jieru Zhou, Lei Jiang, Xianming Fei
  Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
• The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: a tick in another box for sodium-glucose cotransporter 2 inhibitors
  Theocharis Koufakis, George Giannakoulas, Pantelis Zebekakis, Kalliopi Kotsa
  Expert Opinion on Pharmacotherapy.2022; 23(3): 321.     CrossRef
• The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases
  Milijana Janjusevic, Giulia Gagno, Alessandra Lucia Fluca, Laura Padoan, Antonio Paolo Beltrami, Gianfranco Sinagra, Rita Moretti, Aneta Aleksova
  Life Sciences.2022; 289: 120193.     CrossRef
• Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
  Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo
  Heart Failure Reviews.2022; 28(3): 597.     CrossRef
• Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus
  Yu. G. Gorb, S. A. Serik, O. V. Tkachenko, V. V. Ryabukha
  Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2022; 7(1): 14.     CrossRef
• Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients
  Mingyu Hao, Jianxin Deng, Xiaohong Huang, Haiyan Li, Huiting Ou, Xiangsheng Cai, Jiajie She, Xueting Liu, Ling Chen, Shujuan Chen, Wenlan Liu, Dewen Yan
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
  Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Ivan M. Fushtey, Alexander E. Berezin
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
  Rodica Pop-Busui, James L. Januzzi, Dennis Bruemmer, Sonia Butalia, Jennifer B. Green, William B. Horton, Colette Knight, Moshe Levi, Neda Rasouli, Caroline R. Richardson
  Diabetes Care.2022; 45(7): 1670.     CrossRef
• Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study
  Mayila Abudoukelimu, Bayinsilema Ba, Yan Kai Guo, Jie Xu
  Medicine.2022; 101(31): e29854.     CrossRef
• Why Does the Intravenous Iron Supplementation Not Work in Heart Failure Patients on Hemodialysis?
  Jin Joo Park
  CardioMetabolic Syndrome Journal.2022; 2(2): 176.     CrossRef
• Severe hypoglycemia and risk of hospitalization for heart failure in adults with diabetes treated with oral medications with or without insulin: A population-based study
  You-Bin Lee, Yoon-Jong Bae, Hoseob Kim, Jiyun Park, So Yoon Kwon, So Hee Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
  Diabetes Research and Clinical Practice.2022; 192: 110083.     CrossRef
• Blood Pressure Target in Type 2 Diabetes Mellitus
  Hyun-Jin Kim, Kwang-il Kim
  Diabetes & Metabolism Journal.2022; 46(5): 667.     CrossRef
• Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
  Ruxin Wang, Juan Wu, Haowen Ye, Xiaofang Zhang, Lihong Wang
  Medicina.2022; 58(10): 1473.     CrossRef
• HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction
  Jure Bosanac, Lara Straus, Marko Novaković, Daniel Košuta, Mojca Božič Mijovski, Jerneja Tasič, Borut Jug, Azizah Ugusman
  Disease Markers.2022; 2022: 1.     CrossRef
• The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
  Weiyi Xia, Xia Li, Qingping Wu, Aimin Xu, Liangqing Zhang, Zhengyuan Xia
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Microvascular Burden and Incident Heart Failure Among Middle-Aged and Older Adults With Type 1 or Type 2 Diabetes
  Fu-Rong Li, Daniel Nyarko Hukportie, Jing Yang, Huan-Huan Yang, Guo-Chong Chen, Xian-Bo Wu
  Diabetes Care.2022; 45(12): 2999.     CrossRef
• C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
  Jin Joo Park, Minjae Yoon, Hyoung-Won Cho, Hyun-Jai Cho, Kye Hun Kim, Dong Heon Yang, Byung-Su Yoo, Seok-Min Kang, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Dong-Ju Choi
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
  Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti
  Heart Failure Reviews.2021; 28(3): 667.     CrossRef